- Report
- June 2021
- 142 Pages
Global
From €2659EUR$2,750USD£2,284GBP
€5317EUR$5,500USD£4,567GBP
- Report
- March 2018
- 162 Pages
Global
From €1329EUR$1,375USD£1,142GBP
€2659EUR$2,750USD£2,284GBP
- Clinical Trials
- July 2019
- 170 Pages
Global
From €2900EUR$3,000USD£2,491GBP
- Report
- May 2018
- 305 Pages
Global
From €4012EUR$4,150USD£3,446GBP
- Report
- October 2022
- 150 Pages
Global
From €5752EUR$5,950USD£4,941GBP
- Report
- April 2023
- 150 Pages
Global
From €4689EUR$4,850USD£4,028GBP
- Report
- January 2021
- 77 Pages
India
From €3384EUR$3,500USD£2,906GBP
- Report
- June 2018
- 15 Pages
Global
- Report
- May 2018
- 15 Pages
Global
- Report
- July 2022
- 100 Pages
Global
From €2659EUR$2,750USD£2,284GBP
- Report
- November 2023
- 82 Pages
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- November 2023
- 120 Pages
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- February 2023
- 206 Pages
Global
From €3079EUR$3,185USD£2,645GBP
€4399EUR$4,550USD£3,778GBP
- Report
- February 2021
- 118 Pages
From €2030EUR$2,100USD£1,744GBP
€2900EUR$3,000USD£2,491GBP
- Report
- April 2023
- 120 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- August 2020
- 85 Pages
North America
From €4592EUR$4,750USD£3,945GBP
- Report
- January 2020
- 40 Pages
Saudi Arabia
From €2509EUR$2,595USD£2,155GBP
- Report
- January 2020
- 40 Pages
Japan
From €2509EUR$2,595USD£2,155GBP
- Report
- January 2020
- 40 Pages
India
From €2509EUR$2,595USD£2,155GBP
- Report
- January 2020
- 40 Pages
China
From €2509EUR$2,595USD£2,155GBP
The Adult Stem Cell market is a subset of the larger Stem Cell market, which is focused on the use of stem cells for medical treatments. Adult stem cells are found in the body and are used to replace or repair damaged tissue. These cells can be harvested from a patient's own body, or from a donor, and then used to treat a variety of conditions, including cancer, heart disease, and neurological disorders.
The Adult Stem Cell market is driven by the increasing demand for stem cell therapies, as well as the development of new technologies and techniques for harvesting and processing stem cells. Additionally, the market is supported by government funding and private investments.
Companies in the Adult Stem Cell market include Celgene Corporation, Osiris Therapeutics, Inc., Athersys, Inc., and Mesoblast Limited. Show Less Read more